BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Amgen’s Melanoma Drug Shows Promise in Key Trial

  March 20, 2013

   · 

  8 min read
• Drug Development

  Biogen Idec, Inc. (Massachusetts)'s Injectable MS Drug Cut Relapse Rate by 36 Pct

  March 20, 2013

   · 

  5 min read
• BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study

  March 20, 2013

   · 

  5 min read
• Policy

  Lawsuit Contends Thieves in $80 Million Eli Lilly and Company Robbery Aided by Warehouse Schematics

  March 20, 2013

   · 

  1 min read
• FDA

  SFDA Approval for Amoy Diagnostics Co. LTD.'s EML4-ALK Test

  March 20, 2013

   · 

  3 min read
• BioCapital

  Apotex Inc. is in the FDA Dog House, Again

  March 20, 2013

   · 

  1 min read
• Global Telecom Testing Release: Global Clinical Trial Data Collection: a Minefield or a Walk in the Park for Doctors and Participants?

  March 20, 2013

   · 

  7 min read
• Pharm Country

  Access Pharmaceuticals to Host Fourth Quarter and Fiscal Year Investor Call on Wednesday, April 3rd at 11:00am ET

  March 20, 2013

   · 

  2 min read
• Business

  Ignyta Appoints Dr. Tom Huizinga to Scientific Advisory Board

  March 20, 2013

   · 

  1 min read
• Pharm Country

  Savient Pharmaceuticals, Inc. Drug Sales Drop

  March 20, 2013

   · 

  1 min read